Relationship between Serum Transforming Growth Factor <i>β</i>1 Concentrations and the Duration of Type 1 Diabetes Mellitus in Children and Adolescents

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td align="left">DM duration </td><td align="center">HbA1c (%)</td><td align="center">TGF-<i>β</i>1 (pg/mL)</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td align="left">3–6 years</td><td align="center">8.5 ± 2.4</td><td align="center">718 ± 425</td></tr><tr><td align="left">7–10 years</td><td align="center">8.0 ± 1.8</td><td align="center">841 ± 451</td></tr><tr><td align="left">11–14 years</td><td align="center">8.6 ± 1.4</td><td align="center">1069 ± 566</td></tr><tr><td align="left">15–19 years</td><td align="center">9.2 ± 1.8</td><td align="center">1362 ± 607</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Means and standard deviations of HbA1c and TGF-<i>β</i>1 over four consecutive DM duration intervals.

Mediators of Inflammation

tab3

Table 3

Table 3: Relationship between Serum Transforming Growth Factor <i>β</i>1 Concentrations and the Duration of Type 1 Diabetes Mellitus in Children and Adolescents 

Table 3 | Relationship between Serum Transforming Growth Factor β1 Concentrations and the Duration of Type 1 Diabetes Mellitus in Children and Adolescents 